This study investigates the treatment of locally advanced and metastatic pancreatic cancer. It evaluates how well a combination of an investigational device and chemotherapy works for this condition.
The study focuses on evaluating the safety and effectiveness of the treatment. It looks at how patients respond to the treatment and measures their overall health outcomes.
- Who can participate: Adults 18 years and older with locally advanced or metastatic pancreatic cancer can join. Participants must have a measurable lesion and meet specific health criteria, including ECOG performance status and adequate blood counts.
- Study details: Participants will receive an investigational device with chemotherapy.
- Study timelines: The study will last 6 months.